Filing metadata

Accession number
0000950170-25-075425
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
May 20, 2025
Reporting period
May 16, 2025
Description
Insider transaction

Explore SEC Filings Hub